ClinicalTrialsFinder
RecruitingNCT06780176

A Study of Breast Cancer Risk Factors and Outcomes of People in Florida

Genomic and Non-Genomic Factors Associated With Breast Cancer Risk Factors and Outcomes in a Diverse South Florida Population

Sponsor

Memorial Sloan Kettering Cancer Center

Enrollment

800 participants

Start Date

Jan 13, 2025

Study Type

OBSERVATIONAL

Conditions

Breast CancerBreast NeoplasmsBreast Diseases

Summary

The purpose of this study is to understand why different people have different risks and outcomes for breast cancer and non-breast cancer.

Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Patients with BIRADS 0-5, seen in breast radiology clinic at University of Miami (UM), Sylvester Comprehensive Cancer Center (SCCC), Jackson Health Systems (JHS) for biopsy.
  • Any new breast patient seen at UM/SCCC or JHS will be invited to participate in the study.
  • Men and women 18 years of age and older are eligible to participate in the study.

Exclusion Criteria2

  • Patients who are less than 18 years of age will be considered ineligible.
  • Patients unable to complete the survey.

Interventions

OTHERBiospecimen Collection

Blood collection at baseline and time of surgery

DIAGNOSTIC_TESTSurgical Tissue Collection

Tissue collection will be attempted at time of surgery

BEHAVIORALSurvey Collection

Survey collection at baseline, post-surgery, at 1, 3 and 5 year follow up visits

Locations(3)

University of California, Los Angeles (Specimen Analysis only)

Los Angeles, California, United States

University of Miami (Data Collection Only)

Miami, Florida, United States

Memorial Sloan Kettering Cancer Center (All protocol activites)

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06780176

Related Trials

A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors

NCT06157892139 locations

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

NCT0661828763 locations

Early Phase Study of KESONOTIDE™in Participants With Solid Tumours

NCT069260753 locations

Cardiac Outcomes With Near-Complete Estrogen Deprivation

NCT053096553 locations

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

NCT041190243 locations